List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
3550-CL-0002An open-label, multi-centre, extension study investigating the long-term safety of repeated doses of FE200486 given as subcutaneous injections to prostate cancer patients English


English


3550-CL-0009ASP3550 Phase II Study - A Maintenance-Dose-Finding Study of Three-Month Depot in Patients with Prostate Cancer - English


English


3550-CL-0010Phase III Study of ASP3550 – An Open-label, Goserelin Acetate-controlled, Parallel Group Study in Patients with Prostate Cancer – Japanese


Japanese


QUICK SEARCH

USEFUL LINKS